Mannkind: Overlooked Biotech With Excellent Prospects (Part IV) [View article]
Great article AW: You certainly are entitled to your opinion on TI!
However, management has already burned $1.1 billion in develpoing TI. While the current $619 million should last them until 2009/10 (assuming their operating expenses go down as planned), I expect the FDA to adopt a cautious stance if and when the NDA for TI is filed. Tell me, how soon do you think the management can earn the $1.1 billion burnt in TI's development so far? Additionally, I do not see the management launching a new product in the coming 5 years based on their threadbare pipeline beyond TI.
-
Great article AW: You certainly are entitled to your opinion on TI!
Jun 19 06:16 am
|Rating:
0
0
All Comments by V.P. »Mannkind: Overlooked Biotech With Excellent Prospects (Part IV) [View article]
However, management has already burned $1.1 billion in develpoing TI. While the current $619 million should last them until 2009/10 (assuming their operating expenses go down as planned), I expect the FDA to adopt a cautious stance if and when the NDA for TI is filed. Tell me, how soon do you think the management can earn the $1.1 billion burnt in TI's development so far? Additionally, I do not see the management launching a new product in the coming 5 years based on their threadbare pipeline beyond TI.